Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
SNTI
#4018
Senti Biosciences, Inc. Common Stock
0.931
5
USD
-6.40%
Settore:
Salute
Base:
USD
Valuta di Profitto:
USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-6.40%
Variazione Mensile
-2.15%
Variazione di 6 mesi
-2.15%
Variazione Annuale
-2.15%
Chiusura Precedente
0.995
2
Open
0.931
5
Bid
0.931
5
Ask
0.934
5
Low
0.931
5
High
0.931
5
Volume
6
Mercati
Mercato Azionario Statunitense
Salute
SNTI
Open full chart
Financials
Overview
Estratto Conto
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
TTM
Cash from operating activities
—
34.9 M
52.4 M
41.4 M
50.07 M
Cash from investing activities
—
81.96 M
30.08 M
34 K
173 K
Cash from financing activities
—
118.55 M
779 K
53.73 M
52.01 M
Free cash flow
—
-6.48 M
40.36 M
41.37 M
49.87 M
Notizie
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories! - TipRanks.com
Why Is Gene Therapy Focused Senti Bio Stock Falling Today? - Senti Biosciences (NASDAQ:SNTI)
Senti Bio’s SENTI-202 shows promising results in AML clinical trial
Senti Bio stock soars after positive cancer therapy trial results
Leerink Partners avvia copertura su Senti Biosciences con rating Outperform
Senti Bio presenterà dati clinici aggiornati su SENTI-202 al meeting ASH
Senti Bio to present updated clinical data on SENTI-202 at ASH meeting
H.C. Wainwright avvia copertura su Senti Biosciences con rating Buy
Senti Biosciences stock rating initiated at Buy by H.C. Wainwright
Senti Biosciences completes dose finding in AML therapy trial
Senti Bio to present logic-gated CAR-NK cell therapy at BioScience Forum
Senti Bio appoints K5 Global co-founder Bryan Baum to board of directors